Bronchodilator Agents
-
Subject Areas on Research
- 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society.
- A Respiratory Therapist-Driven Asthma Pathway Reduced Hospital Length of Stay in the Pediatric Intensive Care Unit.
- A review of the use of adjunctive therapies in severe acute asthma exacerbation in critically ill children.
- Acute effects of inhaled nitric oxide on pulmonary and cardiac function in preterm infants with evolving bronchopulmonary dysplasia.
- Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease.
- Acute upper airway angioedema secondary to acquired C1 esterase inhibitor deficiency: a case report.
- Aerosol delivery in intubated, mechanically ventilated patients.
- An Asthma Protocol Improved Adherence to Evidence-Based Guidelines for Pediatric Subjects With Status Asthmaticus in the Emergency Department.
- Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease.
- Asthma outcomes: pulmonary physiology.
- Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.
- Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme.
- Beneficial effects of albuterol therapy driven by heliox versus by oxygen in severe asthma exacerbation.
- Bronchiolitis management preferences and the influence of pulse oximetry and respiratory rate on the decision to admit.
- Bronchiolitis.
- Bronchiolitis.
- Bronchodilators in heart failure patients with COPD: is it time for a clinical trial?
- Characterization of the airway smooth muscle muscarinic receptor in vivo.
- Childhood asthma clusters and response to therapy in clinical trials.
- Chronic obstructive pulmonary disease management: the evidence base.
- Chronic obstructive pulmonary disease: emerging medical therapies.
- Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study.
- Consensus statement: aerosols and delivery devices. American Association for Respiratory Care.
- Contamination of nebulizer equipment with cockroach allergen: there's a bug in the system!
- Dispensing home nebulizers for acute wheezing from the hospital is cost-effective.
- Early management of acute severe asthma.
- Effect of lidocaine on endothelin-1-mediated airway smooth muscle contraction in the rat trachea.
- Efficacy of esomeprazole for treatment of poorly controlled asthma.
- Emergent management of acute asthma.
- Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways.
- G protein-coupled receptor kinase 5 regulates airway responses induced by muscarinic receptor activation.
- GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol.
- Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats.
- Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease.
- Intrinsic Xenobiotic Resistance of the Intestinal Stem Cell Niche.
- Management of acute exacerbations of chronic obstructive pulmonary disease.
- Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence.
- Mechanical ventilation strategies in the management of congenital diaphragmatic hernia.
- Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level.
- Pharmacologic treatment of bronchiolitis in infants and children: a systematic review.
- Physician-targeted program on inhaled therapy for childhood asthma.
- Protection from experimental asthma by an endogenous bronchodilator.
- Randomized pilot trial of ipratropium versus placebo in children with critical asthma.
- Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium.
- Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort.
- Risk indexes for exacerbations and hospitalizations due to COPD.
- Safety of a peanut oral immunotherapy protocol in children with peanut allergy.
- Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma.
- Stress, ADCYAP1R1, and Childhood Asthma. No Sigh of Relief.
- The effect of exposure to wood smoke on outcomes of childhood pneumonia in Botswana.
- The effects of direct-to-consumer advertising on medication use among Medicaid children with asthma.
- Tiotropium (Spiriva) for COPD.
- Treatment of acute bronchitis in adults. A national survey of family physicians.
- Using Hyperpolarized 129Xe MRI to Quantify the Pulmonary Ventilation Distribution.
-
Keywords of People
- O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology